SCHEMBL10067183

SCHEMBL10067183

Nc1ccc(Oc2ccc(C(=O)c3ccc(-c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 4/20 0.61
▸ PARP10 Q53GL7 2/20 0.58
▸ MAOA P21397 1/20 0.57
▸ ACACB O00763 1/20 0.52
▸ ACACA Q13085 1/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ TAAR1 Q96RJ0 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ CA12 O43570 2/20 0.51
▸ CA1 P00915 2/20 0.51
▸ CA2 P00918 2/20 0.51
▸ CA9 Q16790 2/20 0.51
▸ CA14 Q9ULX7 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ MEN1 O00255 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15294825 0.93 PARP10 (0.66) SRD5A2PARP10MAOAACACBACACA
SCHEMBL3455050 0.91 SRD5A2 (0.67) SRD5A2PARP10MAOACYP3A4TDP1
4-Phenoxyaniline SCHEMBL29256862 0.91 SRD5A2 (0.72) SRD5A2PARP10MAOACYP3A4TDP1
SCHEMBL12757139 0.91 SRD5A2 (0.71) SRD5A2PARP10ACACBACACAPOLB
SCHEMBL9452100 0.91 SRD5A2 (0.71) SRD5A2PARP10ACACBACACAPOLB
SCHEMBL28412889 0.90 SRD5A2 (0.54) SRD5A2PARP10MAOAACACBACACA
Diphenylether SCHEMBL4392558 0.89 SRD5A2 (0.69) SRD5A2PARP10MAOACYP3A4TDP1
Benzophenone SCHEMBL27796777 0.89 MAOA (0.65) SRD5A2PARP10MAOACYP3A4TDP1
SCHEMBL12757137 0.89 SRD5A2 (0.69) SRD5A2PARP10ACACBACACAPOLB
SCHEMBL6653960 0.89 CYP3A4 (0.65) SRD5A2CYP3A4TDP1TAAR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106142-B2 Polyacetylinic oligomers THE BOEING COMPANY (US) 2012-01-31 — — US disclosed
US-20100204485-A1 POLYACETYLINIC OLIGOMERS THE BOEING COMPANY 2010-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204485-A1 POLYACETYLINIC OLIGOMERS AADAC, ACMSD, ECPAS SRD5A2 2566/4885PARP10 3521/4885MAOA 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback